Liquidia (LQDA) Cash from Operations Growth (5y) (2025 - 2026)

Liquidia (LQDA) Cash from Operations Growth (5y) (2025 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	89.55 Bn	87.69 Bn	-
2	Teva Pharmaceutical Industries	35.91 Bn	32.16 Bn	1.97 Bn
3	Zoetis	32.71 Bn	30.77 Bn	1.62 Bn
4	Takeda Pharmaceutical	27.65 Bn	23.59 Bn	4.39 Bn
5	United Therapeutics	23.18 Bn	21.03 Bn	648.10 Mn
6	RedHill Biopharma	21.80 Bn	21.80 Bn	-
7	Viatris	20.30 Bn	18.50 Bn	1.16 Bn
8	Neurocrine Biosciences	17.84 Bn	16.52 Bn	800.70 Mn
9	Elanco Animal Health	12.64 Bn	12.21 Bn	785.00 Mn
10	Liquidia	7.72 Bn	7.50 Bn	121.79 Mn

Download Data